Stock Movers KB Home Drops, Sarepta Jumps, ARM Gains on Plans to Sell Its Own Chips
Mar 25, 2026
Avalon Pernell, Bloomberg reporter and market commentator who gives concise rundowns of company moves. She breaks down Arm’s plan to sell its own AI chips and the Meta tie-up. She covers KB Home missing delivery forecasts and the market reaction. She also outlines Merck’s takeover of Terns and what moved biotech stocks.
AI Snips
Chapters
Transcript
Episode notes
Watch IP Firms Move Into Product Sales
- Expect tech IP firms to expand into product sales to capture larger AI-driven revenue pools.
- Monitor partners like Meta and manufacturers like TSMC to gauge execution and revenue potential (Arm expects ~$15B in five years).
Arm Enters Chip Sales With AGI CPU
- Arm will start selling its own AI chips for the first time, shifting from pure IP licensing to direct hardware sales.
- Meta is the first major customer and TSMC will manufacture Arm's AGI CPU with up to 136 cores and ~300W draw.
KB Home Forecast Misses Amid Consumer Uncertainty
- KB Home warned Q2 deliveries would miss analyst estimates and reported Q1 revenue and deliveries slightly below expectations.
- Management cited Middle East conflict concerns adding consumer uncertainty atop broader macro challenges.